Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Chemed Corporation (CHE) has a Wall Street consensus price target of $475.00, based on estimates from 9 covering analysts. With the stock currently trading at $410.01, this represents a potential upside of +15.9%. The company has a market capitalization of $5.78B.
Analyst price targets range from a low of $475.00 to a high of $475.00, representing a 0% spread in expectations. The median target of $475.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 4 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, CHE trades at a trailing P/E of 22.3x and forward P/E of 16.8x. Analysts expect EPS to grow +29.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $528.88, with bear and bull scenarios of $232.57 and $782.44 respectively. Model confidence stands at 64/100, reflecting moderate uncertainty in projections.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how CHE stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonChemed Corporation (CHE) has a consensus 12-month price target of $475, implying 15.9% upside from $410.01. The 9 analysts covering CHE see moderate appreciation potential.
CHE has a consensus rating of "Hold" based on 9 Wall Street analysts. The rating breakdown is mixed, with 5 Hold ratings making up the largest segment. The consensus 12-month price target of $475 implies 15.9% upside from current levels.
With a forward P/E of 16.7505x, CHE trades at a relatively low valuation. The consensus target of $475 implies 15.9% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $475 for CHE, while the most conservative target is $475. The consensus of $475 represents the median expectation. Our quantitative valuation model projects a bull case target of $782 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CHE is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 5 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CHE stock forecast based on 9 Wall Street analysts shows a consensus price target of $475, with estimates ranging from $475 (bear case) to $475 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $529, with bear/bull scenarios of $233/$782.
Our quantitative valuation model calculates CHE's fair value at $529 (base case), with a bear case of $233 and bull case of $782. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 64/100.
CHE trades at a forward P/E ratio of 16.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 22.3x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on CHE, with a "Hold" consensus rating and $475 price target (15.9% upside). 4 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CHE analyst price targets range from $475 to $475, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $475 consensus represents the middle ground. Our model's $233-$782 range provides an independent fundamental perspective.